SARS‐CoV‐2 innate effector associations and viral load in early nasopharyngeal infection
초기 비인두 감염에서 SARS-CoV-2 선천적 이펙터 연관성 및 바이러스 부하
Observational Study
[키워드] 95% CI
ACE
age
ambulatory
Antiviral
antiviral gene
antiviral protein
antiviral responses
applied
association
Biomarkers
blocked
BST
cause
Chain Reaction
change
characterized
clinical outcomes
clinical testing
COVID‐19
cytokine
Cytokines
discrepancy
disease
disrupt
early disease
Effects
elevated
Evidence
evidence of
examined
Host
host shut‐off
Hypothesis
IFIT1
IFIT3
IFN
IFN‐γ
immune
immune responses
immunoassays
individual
Infection
Inflammatory cytokines
innate immune
innate immune response
innate immune responses
Innate immunity
interferon
interferons
ISG
Modification
multiplex
nasopharyngeal
Nasopharyngeal swab
nasopharyngeal swab sample
Older age
outcomes
Patient
polymerase chain
polymerase chain reaction
polymerase chain reaction assays
Proinflammatory cytokine
Protein
proteomics
Quantitative
responses
SARS‐CoV‐2
SARS‐CoV‐2 infection
SARS‐CoV‐2
severe disease
subsequent
Symptom
symptomatic patient
systemic inflammatory
tested
transcribed
transcript
Transcription
transcripts
translated
translation
university
Utah
Viral
viral infection
Viral load
widespread
with infection
[DOI] 10.14814/phy2.14761 PMC 바로가기 [Article Type] Observational Study
[DOI] 10.14814/phy2.14761 PMC 바로가기 [Article Type] Observational Study